Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Meignier

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
The Journal of Infectious Diseases|September 1, 1988
In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020: construction and evaluation in rodentsB Meignier, R Longnecker, B Roizman
Vaccine|June 1, 1990
Molecular genetics of the rotavirusesJ Cohen, B Meignier, S A Plotkin
Journal of Virology|August 1, 1985
Establishment of latency in mice by herpes simplex virus 1 recombinants that carry insertions affecting regulation of the thymidine kinase geneA E Sears, B Meignier, B Roizman
Vaccine|January 1, 1992
Comparison of the ability of formalin-inactivated respiratory syncytial virus, immunopurified F, G and N proteins and cell lysate to enhance pulmonary changes in Balb/c miceF Vaux-Peretz, J M Chapsal, B Meignier
The Journal of Infectious Diseases|August 1, 1990
In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020. II. Studies in immunocompetent and immunosuppressed owl monkeys (Aotus trivirgatus)B Meignier, B Martin, R J Whitley, et al.
Developments in Biological Standardization|January 1, 1995
Highly attenuated poxvirus vectors: NYVAC, ALVAC and TROVACE Paoletti, J Taylor, B Meignier, et al.
Cytotechnology|November 13, 2008
Characterization of Vero cell growth and death in bioreactor with serum-containing and serum-free mediaS Quesney, J Marvel, A Marc, et al.
The Journal of Infectious Diseases|May 1, 1987
Immunization of experimental animals with reconstituted glycoprotein mixtures of herpes simplex virus 1 and 2: protection against challenge with virulent virusB Meignier, T M Jourdier, B Norrild, et al.
Journal of Virology|August 1, 1985
Herpes simplex virus 1 mutant deleted in the alpha 22 gene: growth and gene expression in permissive and restrictive cells and establishment of latency in miceA E Sears, I W Halliburton, B Meignier, et al.
Virology|January 1, 1988
Virulence of and establishment of latency by genetically engineered deletion mutants of herpes simplex virus 1B Meignier, R Longnecker, P Mavromara-Nazos, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
The Journal of Infectious Diseases|September 1, 1988
In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020: construction and evaluation in rodentsB Meignier, R Longnecker, B Roizman
Vaccine|June 1, 1990
Molecular genetics of the rotavirusesJ Cohen, B Meignier, S A Plotkin
Journal of Virology|August 1, 1985
Establishment of latency in mice by herpes simplex virus 1 recombinants that carry insertions affecting regulation of the thymidine kinase geneA E Sears, B Meignier, B Roizman
Vaccine|January 1, 1992
Comparison of the ability of formalin-inactivated respiratory syncytial virus, immunopurified F, G and N proteins and cell lysate to enhance pulmonary changes in Balb/c miceF Vaux-Peretz, J M Chapsal, B Meignier
The Journal of Infectious Diseases|August 1, 1990
In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020. II. Studies in immunocompetent and immunosuppressed owl monkeys (Aotus trivirgatus)B Meignier, B Martin, R J Whitley, et al.
Developments in Biological Standardization|January 1, 1995
Highly attenuated poxvirus vectors: NYVAC, ALVAC and TROVACE Paoletti, J Taylor, B Meignier, et al.
Cytotechnology|November 13, 2008
Characterization of Vero cell growth and death in bioreactor with serum-containing and serum-free mediaS Quesney, J Marvel, A Marc, et al.
The Journal of Infectious Diseases|May 1, 1987
Immunization of experimental animals with reconstituted glycoprotein mixtures of herpes simplex virus 1 and 2: protection against challenge with virulent virusB Meignier, T M Jourdier, B Norrild, et al.
Journal of Virology|August 1, 1985
Herpes simplex virus 1 mutant deleted in the alpha 22 gene: growth and gene expression in permissive and restrictive cells and establishment of latency in miceA E Sears, I W Halliburton, B Meignier, et al.
Virology|January 1, 1988
Virulence of and establishment of latency by genetically engineered deletion mutants of herpes simplex virus 1B Meignier, R Longnecker, P Mavromara-Nazos, et al.
Pageof 5